Veterinary Vaccines: Global Markets

June 2023 | 313 pages | ID: VB44967F7D05EN
BCC Research

Abstracts

Report Scope:

This report aims to provide a comprehensive study of the global market for veterinary vaccines. It describes the different types of veterinary vaccines products, technology, and their current and historical market revenues.

Veterinary vaccines include designs and different technology along with applications. The product of veterinary vaccines are segmented into attenuated vaccine (live vaccine, modified live vaccine, live attenuated vaccine), inactivated vaccine, recombinant vaccine (subunit vaccine, polysaccharide vaccine, conjugate vaccine, chimeric vaccine, viral-vector vaccine), and toxoid vaccine.

This report also covers a detailed study of animal species in the veterinary vaccines market, including livestock, poultry, companion animals, swine, equine, and others (aquaculture, etc.) An in-depth analysis of the global market for veterinary vaccines includes historical data and market projections on sales by technology/system type, product, application, design, and region.

For an in-depth understanding of the market, profiles of market participants, essential marketed products, competitive landscape, key competitors, ESG analysis, and their respective market shares have been provided. This report also discusses the driving and restraining factors of the global veterinary vaccines market.

Report Includes:

• 145 data tables and 45 additional tables
• A comprehensive overview of the current and future global markets for veterinary vaccines
• Analyses of the global market trends, with historic market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for global veterinary vaccines market in USD millions, and corresponding market share analysis based on the product, type of attenuated and recombinant vaccines, animal type, route of administration, and region
• Highlights of upcoming market opportunities and trends driving and restricting growth of global veterinary vaccines market and its sub-segments, and major regions and countries involved in the market developments
• In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and various macroeconomics factors influencing the demand and progress of this market
• Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, France, Italy, Spain, the UK, Japan, China, India, Australia and New Zealand (ANZ), Brazil, Argentina, South Africa, and GCC countries, among others
• Information about ESG-related developments in the animal health industry, key issues, implementation strategies, and analyses of factors affecting ESG applications in the market
• Identification of the companies engaged in research and development (R&D) of vaccination and vaccine production, emerging technologies, and a SWOT analysis of leading competitors and their market penetration
• Company profiles of major players within the industry, including Boehringer Ingelheim, Dechra, Elanco, Merck & Co. Inc., and Zoetis Services LLC

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Market Outlook

CHAPTER 3 MARKET OVERVIEW

Overview of Veterinary Vaccines
Animal Types and Vaccination
Livestock
Companion Animals
Equine Animals
Swine
Poultry
Other Animals
Vaccines and Veterinary Products Export
Trends in Animal Healthcare
Growing Demand for Animal Health Products

CHAPTER 4 MARKET DYNAMICS

Market Dynamics
Drivers
Incidence and Prevalence of Animal Disease
Global Warming and Impact on Veterinary Animals
Increase in Investment for Treating and Eradicating Diseases in Animals
Emergence of Zoonotic Diseases
Rise in Awareness Programs on Veterinary Vaccines
Vaccines and Food Production
Restraints
Product Development and Manufacturing Challenges
Side Effects of Vaccination
Financial Prioritization and Herd Immunity Risk
Other Restraints
Opportunities
Launch of New Veterinary Vaccines
Reducing the Need for Antibiotics
Funding for Innovative Veterinary Vaccines and Services

CHAPTER 5 IMPACT OF COVID-19 ON ANIMAL HEALTH AND PRODUCTION FACILITIES

Overview
Short-Term Impact
Long-Term Impact
COVID-19 Impact on Animal Welfare
Animal Disease Management
Vaccination Campaigns

CHAPTER 6 EMERGING TECHNOLOGIES IN VETERINARY VACCINES

Overview
Multivalent Veterinary Vaccines
mRNA Vaccine
Pipeline Analysis of Animal Vaccines

CHAPTER 7 GLOBAL MARKET FOR VETERINARY VACCINES, BY PRODUCT

Introduction
Attenuated Vaccine
Inactivated Vaccine
Toxoid Vaccines
Recombinant Vaccine

CHAPTER 8 GLOBAL MARKET FOR VETERINARY VACCINES, BY TYPE OF ANIMAL

Overview
Market Outlook
Livestock
Poultry
Companion Animals
Swine
Equine
Other Animals

CHAPTER 9 GLOBAL MARKET FOR VETERINARY VACCINES, BY ADMINISTRATION

Global Market for Veterinary Vaccines by Administration
Subcutaneous Route of Administration
Intramuscular Route of Administration
Intranasal Route of Administration
Oral Route of Administration

CHAPTER 10 GLOBAL MARKET FOR VETERINARY VACCINES, BY REGION

Global Markets for Veterinary Vaccines by Region
North America
United States
Canada
Mexico
Europe
Germany
Italy
France
United Kingdom
Spain
Rest of Europe
Asia-Pacific
Japan
India
Australia and New Zealand
China
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East & Africa

CHAPTER 11 COMPETITIVE LANDSCAPE

Global Analysis of Company Shares
SWOT Analysis

CHAPTER 12 M&A AND FUNDING OUTLOOK

M&A Analysis
Fundings in Animal Healthcare

CHAPTER 13 SUSTAINABILITY OF THE ANIMAL HEALTH INDUSTRY: AN ESG PERSPECTIVE

Overview of ESG
Key ESG Issues in the Animal Healthcare Industry
Animal Health Industry ESG Performance Analysis

CHAPTER 14 COMPANY PROFILES

ARKO LABORATORIES
AVIMEX
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CEVA SANTE ANIMALE (CEVA)
DECHRA PHARMACEUTICALS.
ELANCO.
MERCK & CO. INC.
PHIBRO ANIMAL HEALTH CORP.
VIRBAC
ZOETIS SERVICES LLC.

List Of Tables

LIST OF TABLES

Summary Table: Global Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 1: Subunit and Recombinant Protein Vaccines
Table 2: DIVA Vaccines
Table 3: Dairy Livestock Infection Category Vaccination
Table 4: Vaccines for Companion Animals
Table 5: Vaccines for Equine Infections
Table 6: Vaccines for Swine Infection
Table 7: Vaccines for Poultry Infection
Table 8: Vaccines for Other Animals Infections
Table 9: Vaccines and Veterinary Medicines Exports, by Country, 2021
Table 10: List of Different Types of Diseases in Animals
Table 11: Number of Outbreaks, Cases and Animal Losses Caused by ASF, 2021
Table 12: Coronavirus Reported Cases and Deaths, by Country, 2020
Table 13: Pipeline Analysis of Animal Vaccines
Table 14: Global Market for Veterinary Vaccines, by Product, Through 2028
Table 15: Global Market for Attenuated Vaccines, Through 2028
Table 16: Global Market for Recombinant Vaccines, Through 2022
Table 17: Veterinary Vaccines in Aquaculture
Table 18: Global Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 19: Global Meat Trade, by Beef and Sheep
Table 20: Global Poultry Trade
Table 21: Global Swine Trade
Table 22: Global Market for Veterinary Vaccines, by Administration, Through 2028
Table 23: Global Market for Veterinary Vaccines, by Region, Through 2028
Table 24: North American Market for Veterinary Vaccines, by Product, Through 2028
Table 25: North American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 26: North American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 27: North American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 28: North American Market for Veterinary Vaccines, by Administration, Through 2028
Table 29: North American Market for Veterinary Vaccines, by Country, Through 2028
Table 30: U.S. Market for Veterinary Vaccines, by Product, Through 2028
Table 31: U.S. Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 32: U.S. Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 33: U.S. Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 34: U.S. Market for Veterinary Vaccines, by Administration, Through 2028
Table 35: United States Pets Vaccine Cost
Table 36: Canadian Market for Veterinary Vaccines, by Product, Through 2028
Table 37: Canadian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 38: Canadian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 39: Canadian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 40: Canadian Market for Veterinary Vaccines, by Administration, Through 2028
Table 41: Flocks Confirmed with Avian Influenza in Canada, 2021
Table 42: Mexican Market for Veterinary Vaccines, by Product, Through 2028
Table 43: Mexican Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 44: Mexican Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 45: Mexican Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 46: Mexican Market for Veterinary Vaccines, by Administration, Through 2028
Table 47: European Market for Veterinary Vaccines, by Product, Through 2028
Table 48: European Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 49: European Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 50: European Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 51: European Market for Veterinary Vaccines, by Administration, Through 2028
Table 52: European Market for Veterinary Vaccines, by Country, Through 2028
Table 53: German Market for Veterinary Vaccines, by Product, Through 2028
Table 54: German Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 55: German Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 56: German Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 57: German Market for Veterinary Vaccines, by Administration, Through 2028
Table 58: Italian Market for Veterinary Vaccines, by Product, Through 2028
Table 59: Italian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 60: Italian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 61: Italian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 62: Italian Market for Veterinary Vaccines, by Administration, Through 2028
Table 63: Number of Enzootic Bovine Leukosis Breakouts in Italy Region, 2011-2020
Table 64: French Market for Veterinary Vaccines, by Product, Through 2028
Table 65: French Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 66: French Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 67: French Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 68: French Market for Veterinary Vaccines, by Administration, Through 2028
Table 69: U.K. Market for Veterinary Vaccines, by Product, Through 2028
Table 70: U.K. Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 71: U.K. Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 72: U.K. Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 73: U.K. Market for Veterinary Vaccines, by Administration, Through 2028
Table 74: Spanish Market for Veterinary Vaccines, by Product, Through 2028
Table 75: Spanish Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 76: Spanish Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 77: Spanish Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 78: Spanish Market for Veterinary Vaccines, by Administration, Through 2028
Table 79: Rest of European Market for Veterinary Vaccines, by Product, Through 2028
Table 80: Rest of European Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 81: Rest of European Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 82: Rest of European Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 83: Rest of European Market for Veterinary Vaccines, by Administration, Through 2028
Table 84: Asia-Pacific Market for Veterinary Vaccines, by Product, Through 2028
Table 85: Asia-Pacific Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 86: Asia-Pacific Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 87: Asia-Pacific Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 88: Asia-Pacific Market for Veterinary Vaccines, by Administration, Through 2028
Table 89: Asia-Pacific Market for Veterinary Vaccines, by Country, Through 2028
Table 90: Japanese Market for Veterinary Vaccines, by Product, Through 2028
Table 91: Japanese Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 92: Japanese Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 93: Japanese Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 94: Japanese Market for Veterinary Vaccines, by Administration, Through 2028
Table 95: Indian Market for Veterinary Vaccines, by Product, Through 2028
Table 96: Indian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 97: Indian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 98: Indian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 99: Indian Market for Veterinary Vaccines, by Administration, Through 2028
Table 100: Australian and New Zealand Market for Veterinary Vaccines, by Product, Through 2028
Table 101: Australian and New Zealand Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 102: Australian and New Zealand Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 103: Australian and New Zealand Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 104: Australian and New Zealand Market for Veterinary Vaccines, by Administration, Through 2028
Table 105: Chinese Market for Veterinary Vaccines, by Product, Through 2028
Table 106: Chinese Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 107: Chinese Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 108: Chinese Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 109: Chinese Market for Veterinary Vaccines, by Administration, Through 2028
Table 110: Rest of Asia-Pacific Market for Veterinary Vaccines, by Product, Through 2028
Table 111: Rest of Asia-Pacific Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 112: Rest of Asia-Pacific Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 113: Rest of Asia-Pacific Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 114: Rest of Asia-Pacific Market for Veterinary Vaccines, by Administration, Through 2028
Table 115: Latin American Market for Veterinary Vaccines, by Product, Through 2028
Table 116: Latin American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 117: Latin American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 118: Latin American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 119: Latin American Market for Veterinary Vaccines, by Administration, Through 2028
Table 120: Latin American Market for Veterinary Vaccines, by Country, Through 2028
Table 121: Brazilian Market for Veterinary Vaccines, by Product, Through 2028
Table 122: Brazilian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 123: Brazilian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 124: Brazilian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 125: Brazilian Market for Veterinary Vaccines, by Administration, Through 2028
Table 126: Argentinian Market for Veterinary Vaccines, by Product, Through 2028
Table 127: Argentinian Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 128: Argentinian Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 129: Argentinian Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 130: Argentinian Market for Veterinary Vaccines, by Administration, Through 2028
Table 131: Argentinian Veterinary Vaccines Importers
Table 132: Rest of Latin American Market for Veterinary Vaccines, by Product, Through 2028
Table 133: Rest of Latin American Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 134: Rest of Latin American Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 135: Rest of Latin American Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 136: Rest of Latin American Market for Veterinary Vaccines, by Administration, Through 2028
Table 137: Middle East & African Market for Veterinary Vaccines, by Product, Through 2028
Table 138: Middle East & African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 139: Middle East & African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 140: Middle East & African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 141: Middle East & African Market for Veterinary Vaccines, by Administration, Through 2028
Table 142: Middle East & African Market for Veterinary Vaccines, by Country, Through 2028
Table 143: Potential Research Collaborations
Table 144: GCC Countries Market for Veterinary Vaccines, by Product, Through 2028
Table 145: GCC Countries Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 146: GCC Countries Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 147: GCC Countries Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 148: GCC Countries Market for Veterinary Vaccines, by Administration, Through 2028
Table 149: South African Market for Veterinary Vaccines, by Product, Through 2028
Table 150: South African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 151: South African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 152: South African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 153: South African Market for Veterinary Vaccines, by Administration, Through 2028
Table 154: Rest of Middle East and African Market for Veterinary Vaccines, by Product, Through 2028
Table 155: Rest of Middle East and African Market for Veterinary Vaccines, by Attenuated Vaccines, Through 2028
Table 156: Rest of Middle East and African Market for Veterinary Vaccines, by Recombinant Vaccines, Through 2028
Table 157: Rest of Middle East and African Market for Veterinary Vaccines, by Type of Animal, Through 2028
Table 158: Rest of Middle East and African Market for Veterinary Vaccines, by Administration, Through 2028
Table 159: Company Growth Ratio and Income Values
Table 160: SWOT Analysis: Market for Veterinary Vaccines
Table 161: M&A among Animal Healthcare Companies, 2021
Table 162: Startup Funding in Animal Healthcare, January 2022 to March 2023
Table 163: Arko Laboratories: Animal Vaccine Products
Table 164: Avimex: Animal Vaccine Products
Table 165: Avimex: Development and Strategy
Table 166: Boehringer Ingelheim: Annual Revenue, 2022
Table 167: Boehringer Ingelheim: News
Table 168: Boehringer Ingelheim: Animal Vaccine Products
Table 169: Ceva: Annual Revenue, 2022
Table 170: Ceva: News
Table 171: Ceva: Animal Vaccine Products
Table 172: Dechra: Annual Revenue, 2022
Table 173: Dechra: News
Table 174: Dechra: Animal Vaccine Products
Table 175: Annual Revenue, 2022
Table 176: Elanco: News
Table 177: Elanco: Animal Vaccine Products
Table 178: Merck & Co. Inc.: Annual Revenue, 2022
Table 179: Merck & Co. Inc.: News
Table 180: Merck & Co. Inc.: Animal Vaccine Products
Table 181: Phibro Animal Health Corp.: Annual Revenue, 2022
Table 182: Phibro Animal Health Corp.: News
Table 183: Phibro Animal Health Corp.: Animal Vaccine Products
Table 184: Virbac: Annual Revenue, 2021
Table 185: Virbac: News
Table 186: Virbac: Animal Vaccine Products
Table 187: Zoetis Services LLC: Annual Revenue, 2021
Table 188: Zoetis Services LLC: News
Table 189: Zoetis Services LLC: Animal Vaccine Products

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 1: Top Manufacturers in Animal Health Products
Figure 2: Increase in Livestock Commodity Production, 2020-2030
Figure 3: Pet Populations in Major Regions
Figure 4: Rise in Consumer Spending on Pets, 2016-2021
Figure 5: Comparison of Japan and the U.S. on Animal Life Expectancy
Figure 6: Snapshot of Genes, Single-Nucleotide Polymorphisms (SNPs), and Quantitative Trait Loci (QTL) Related to Cattle Longevity
Figure 7: New Tuberculosis Herd Incidents, Wales, 2022
Figure 8: Animals Slaughtered for TB Control, Wales, 2008-2022
Figure 9: Number of Countries Affected by HPAI, 2005-2021
Figure 10: Worldwide Distribution of SARS-CoV-2 Outbreaks in 23 Animals Species
Figure 11: Factors Affecting Livestock Diseases in African Countries
Figure 12: Drivers of Zoonotic Outbreaks
Figure 13: Livestock Pathogens and Zoonoses
Figure 14: Growing Population of the World
Figure 15: Global Production of Meat and Eggs
Figure 16: Barriers to Animal Vaccination
Figure 17: Modalities for Purchasing Rabies Vaccine from World Vaccine Bank, 2012-2021
Figure 18: Impact of COVID-19 on Pharma Industry
Figure 19: SARS CoV-2 Infections in Non-Human Animals
Figure 20: Impact of COVID-19 on Species Group
Figure 21: Impact of COVID-19 on Species Group, by Country
Figure 22: Impact of COVID-19 on Different Input Issues
Figure 23: Global Animal Disease Cases, 2005–2021
Figure 24: Patent Volumes: Multivalent Veterinary Vaccines
Figure 25: Global Market Shares of Veterinary Vaccines, by Product, 2022
Figure 26: Global Market Shares of Attenuated Vaccines, 2022
Figure 27: Global Market Shares of Recombinant Vaccines, 2022
Figure 28: Global Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 29: Growth of Meat Production, by Region, 2019-2023
Figure 30: Confirmed Cases of SARS-CoV-2 in the U.S., by Type of Animal, 2023
Figure 31: Pet Ownership in Europe, by Type of Animal, 2023
Figure 32: Global Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 33: Global Market Shares of Veterinary Vaccines, by Region, 2022
Figure 34: North American Beef Cattle Inventory, 2000-2022
Figure 35: North American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 36: North American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 37: North American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 38: North American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 39: North American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 40: North American Market Shares of Veterinary Vaccines, by Country, 2022
Figure 41: U.S. Cattle Inventory
Figure 42: U.S. Market Shares of Veterinary Vaccines, by Product, 2022
Figure 43: U.S. Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 44: U.S. Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 45: U.S. Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 46: U.S. Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 47: Canadian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 48: Canadian Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 49: Canadian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 50: Canadian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 51: Canadian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 52: Mexican Market Shares of Veterinary Vaccines, by Product, 2022
Figure 53: Mexican Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 54: Mexican Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 55: Mexican Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 56: Mexican Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 57: European Market Shares of Veterinary Vaccines, by Product, 2022
Figure 58: European Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 59: European Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 60: European Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 61: European Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 62: European Market Shares of Veterinary Vaccines, by Country, 2022
Figure 63: German Market Shares of Veterinary Vaccines, by Product, 2022
Figure 64: German Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 65: German Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 66: German Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 67: German Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 68: Italian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 69: Italian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 70: Italian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 71: Italian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 72: Italian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 73: French Market Shares of Veterinary Vaccines, by Product, 2022
Figure 74: French Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 75: French Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 76: French Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 77: French Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 78: U.K. Market Shares of Veterinary Vaccines, by Product, 2022
Figure 79: U.K. Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 80: U.K. Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 81: U.K. Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 82: U.K. Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 83: Spanish Market Shares of Veterinary Vaccines, by Product, 2022
Figure 84: Spanish Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 85: Spanish Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 86: Spanish Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 87: Spanish Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 88: Rest of European Market Shares of Veterinary Vaccines, by Product, 2022
Figure 89: Rest of European Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 90: Rest of European Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 91: Rest of European Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 92: Rest of European Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 93: Growing Consumer Spending on Companion Animals
Figure 94: Asia-Pacific Market Shares of Veterinary Vaccines, by Product, 2022
Figure 95: Asia-Pacific Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 96: Asia-Pacific Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 97: Asia-Pacific Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 98: Asia-Pacific Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 99: Asia-Pacific Market Shares of Veterinary Vaccines, by Country, 2022
Figure 100: Japanese Market Shares of Veterinary Vaccines, by Product, 2022
Figure 101: Japanese Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 102: Japanese Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 103: Japanese Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 104: Japanese Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 105: Japanese Cat and Dog Ownership
Figure 106: Indian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 107: Indian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 108: Indian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 109: Indian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 110: Indian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 111: Australian and New Zealand Market Shares of Veterinary Vaccines, by Product, 2022
Figure 112: Australian and New Zealand Market Shares of Veterinary Vaccines, by Attenuated Vaccine, 2022
Figure 113: Australian and New Zealand Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 114: Australian and New Zealand Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 115: Australian and New Zealand Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 116: Chinese Market Shares of Veterinary Vaccines, by Product, 2022
Figure 117: Chinese Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 118: Chinese Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 119: Chinese Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 120: Chinese Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 121: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Product, 2022
Figure 122: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 123: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 124: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 125: Rest of Asia-Pacific Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 126: Latin American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 127: Latin American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 128: Latin American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 129: Latin American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 130: Latin American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 131: Latin American Market Shares of Veterinary Vaccines, by Country, 2022
Figure 132: Brazilian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 133: Brazilian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 134: Brazilian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 135: Brazilian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 136: Brazilian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 137: Argentinian Market Shares of Veterinary Vaccines, by Product, 2022
Figure 138: Argentinian Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 139: Argentinian Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 140: Argentinian Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 141: Argentinian Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 142: Number of Beef Cattle Vaccinated Against Foot-and-Mouth Disease in Argentina, 2018, by Province
Figure 143: Rest of Latin American Market Shares of Veterinary Vaccines, by Product, 2022
Figure 144: Rest of Latin American Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 145: Rest of Latin American Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 146: Rest of Latin American Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 147: Rest of Latin American Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 148: Middle East & African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 149: Middle East & African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 150: Middle East & African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 151: Middle East & African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 152: Middle East & African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 153: Middle East & African Market Shares of Veterinary Vaccines, by Country, 2022
Figure 154: GCC Countries Market Shares of Veterinary Vaccines, by Product, 2022
Figure 155: GCC Countries Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 156: GCC Countries Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 157: GCC Countries Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 158: GCC Countries Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 159: South African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 160: South African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 161: South African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 162: South African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 163: South African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 164: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Product, 2022
Figure 165: Rest of the Middle East and African Market Shares of Veterinary Vaccines, by Attenuated Vaccines, 2022
Figure 166: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Recombinant Vaccines, 2022
Figure 167: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Type of Animal, 2022
Figure 168: Rest of Middle East and African Market Shares of Veterinary Vaccines, by Administration, 2022
Figure 169: Global Market Shares of Veterinary Vaccines, by Company, 2022
Figure 170: Top Animal Health Mergers and Acquisitions Worldwide, 2014-2018, by Enterprise Value
Figure 171: M&A among Animal Healthcare Companies Deals in 2021
Figure 172: Healthier Animals: A Solution To Significant Global Challenges
Figure 173: ESG Risk Rating of Top Companies
Figure 174: Boehringer Ingelheim: Annual Revenue, 2021 and 2022
Figure 175: Boehringer Ingelheim: Revenue Shares, by Business Unit, 2022
Figure 176: Boehringer Ingelheim: Revenue Shares, by Country/Region, 2022
Figure 177: Ceva: Annual Revenue, 2021-2022
Figure 178: Dechra: Annual Revenue, 2021 and 2022
Figure 179: Dechra: Revenue Shares, by Business Unit, 2022
Figure 180: Dechra: Revenue Shares, by Country/Region, 2022
Figure 181: Elanco: Annual Revenue, 2021 and 2022
Figure 182: Elanco: Revenue Shares, by Business Unit, 2022
Figure 183: Elanco: Revenue Shares, by Country/Region, 2022
Figure 184: Merck & Co. Inc.: Annual Revenue, 2021 and 2022
Figure 185: Merck & Co. Inc.: Revenue Shares, by Business Unit, 2022
Figure 186: Merck & Co. Inc.: Revenue Shares, by Country/Region, 2022
Figure 187: Phibro Animal Health Corp.: Annual Revenue, 2021 and 2022
Figure 188: Phibro Animal Health Corp.: Revenue Shares, by Business Unit, 2022
Figure 189: Phibro Animal Health Corp.: Revenue Shares, by Country/Region, 2022
Figure 190: Virbac: Annual Revenue, 2020 and 2021
Figure 191: Virbac: Revenue Shares, by Business Unit, 2022
Figure 192: Zoetis Services LLC: Annual Revenue, 2020 and 2021
Figure 193: Zoetis Services LLC: Revenue Shares, by Business Unit, 2022
Figure 194: Zoetis Services LLC: Revenue Shares, by Country/Region, 2022